drugset / Trial / NCT05976503

A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol

NCT05976503 ↗

Phase 1 Completed 22 enrolled Yangtze River Pharmaceutical Group Co., Ltd.
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is primarily to evaluate the effects of simultaneous administration of Tunodafil Hydrochloride Tablets with alcohol on blood pressure, pulse rate and pharmacokinetics in healthy Chinese male participants.

Timeline

Start
2022-12-19
Primary completion
2023-03-08
Completion
2023-03-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Tunodafil Small molecule 50 mg Oral
Subject Tunodafil Small molecule 100 mg Oral

Indications